1. Infectious Diseases Society of America. Bad Bugs, No Drugs (IDSA, 2004), available at http://www.fda.gov/ohrms/dockets/dockets/04s0233/04s-0233-c000005-03-IDSA-vol1.pdf .
2. ECDC. Antimicrobial Resistance Surveillance in Europe. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) (European Centre for Disease Prevention and Control, 2011), available at http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2011.pdf .
3. Lazarev, V. N. & Govorun, V. M. Antimicrobial peptides and their use in medicine. Appl. Biochem. Microbiol. 46, 803–814 (2010).
4. Whitfield, C., Schoenhals, G. & Graham, L. Mutants of Escherichia coli O9:K30 with altered synthesis and expression of the capsular K30 antigen. J. Gen. Microbiol. 135, 2589–2599 (1989).
5. Kolkman, M. A., van der Zeijst, B. A. & Nuijten, P. J. Functional analysis of glycosyltransferases encoded by the capsular polysaccharide biosynthesis locus of Streptococcus pneumoniae serotype 14. J. Biol. Chem. 272, 19502–19508 (1997).